bioMerieux S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR2.17 |
Market Cap |
EUR8.57 B |
Shares Outstanding |
118.36 M |
Public Float |
38.97 M |
Address |
376, chemin de l'Orme Marcy l'Etoile Rhone-Alpes 69280 France |
Employees | - |
Website | http://www.biomerieux.com |
Updated | 07/08/2019 |
bioMérieux SA engages in the provision of diagnostic solutions which determine the source of disease and contamination. The company provides clinical solutions such as antimicrobial resistance, C. difficile infection, human immunodeficiency virus, and emergency department patient management. |